Isoniazid/pyrazinamideDrug-induced hepatitis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1911卷 / 1期

关键词：

D O I：

10.1007/s40278-022-17548-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：251 / 251

相关论文

共 50 条

[1] Rifampicin/isoniazid/pyrazinamideDrug-induced liver injury: case report
Reactions Weekly, 2025, 2040 (1) : 865 - 865
[2] Amikacin/isoniazid/pyrazinamideDrug-induced hepatitis and acute kidney injury: 5 case reports
Reactions Weekly, 2022, 1911 (1) : 26 - 26
[3] Cotrimoxazole/pyrazinamideDrug-induced liver injury: case report
Reactions Weekly, 2023, 1943 (1) : 233 - 233
[4] PyrazinamideDrug-related hepatitis: case report
Reactions Weekly, 2015, 1573 (1) : 193 - 193
[5] Isoniazid/pembrolizumabDrug-induced hepatitis: case report
Reactions Weekly, 2023, 1959 (1) : 345 - 345
[6] Ethambutol/rifampicin/isoniazid/pyrazinamideDrug induced liver injury: 4 case reports
Reactions Weekly, 2022, 1934 (1) : 190 - 190
[7] PyrazinamideDrug allergy: case report
Reactions Weekly, 2019, 1757 (1) : 268 - 268
[8] PyrazinamideDrug resistance: case report
Reactions Weekly, 2022, 1910 (1) : 414 - 414
[9] PyrazinamideDrug rash with photosensitivity: case report
Reactions Weekly, 2010, 1305 (1) : 24 - 24
[10] Ethambutol/isoniazid/rifampicinFulminant hepatitis: case report
Reactions Weekly, 2019, 1784 (1) : 121 - 121

← 1 2 3 4 5 →